Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Common Equity: 2009-2025

Historic Common Equity for Prestige Consumer Healthcare (PBH) over the last 17 years, with Mar 2025 value amounting to $1.8 billion.

  • Prestige Consumer Healthcare's Common Equity rose 5.38% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 5.38%. This contributed to the annual value of $1.8 billion for FY2025, which is 10.86% up from last year.
  • As of FY2025, Prestige Consumer Healthcare's Common Equity stood at $1.8 billion, which was up 10.86% from $1.7 billion recorded in FY2024.
  • Prestige Consumer Healthcare's 5-year Common Equity high stood at $1.8 billion for FY2025, and its period low was $1.4 billion during FY2021.
  • In the last 3 years, Prestige Consumer Healthcare's Common Equity had a median value of $1.7 billion in 2024 and averaged $1.6 billion.
  • Its Common Equity has fluctuated over the past 5 years, first increased by 16.15% in 2022, then fell by 8.27% in 2023.
  • Yearly analysis of 5 years shows Prestige Consumer Healthcare's Common Equity stood at $1.4 billion in 2021, then climbed by 16.15% to $1.6 billion in 2022, then decreased by 8.27% to $1.4 billion in 2023, then increased by 14.37% to $1.7 billion in 2024, then rose by 10.86% to $1.8 billion in 2025.